Uss Investment Management LTD Viatris Inc Transaction History

Uss Investment Management LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $123,966 - $148,266	12,335 Added 2.83%	448,374 $4.77 Million
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $51,842 - $62,238	-4,600 Reduced 1.04%	436,039 $5.21 Million
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $582,512 - $720,667	66,421 Added 17.75%	440,639 $4.77 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $383,015 - $453,307	39,939 Added 11.95%	374,218 $3.69 Million
Q4 2022 Feb 13, 2023	SELL	$8.72 - $11.56 $252,505 - $334,742	-28,957 Reduced 7.97%	334,279 $3.72 Million
Q3 2022 Nov 08, 2022	SELL	$8.48 - $11.13 $273,861 - $359,443	-32,295 Reduced 8.16%	363,236 $3.1 Million
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $911,031 - $1.12 Million	-91,561 Reduced 18.8%	395,531 $4.14 Million
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $919,079 - $1.44 Million	93,688 Added 23.81%	487,092 $5.3 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $688,748 - $786,472	51,981 Added 15.22%	393,404 $5.33 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $4.88 Million - $6.4 Million	341,423 New	341,423 $6.4 Million

1,135

987M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Uss Investment Management LTD with notifications on news.